Presence of PIVKA II at day 5: 0.2 mg IM versus 0.5 mg IM · preterm infants
Higher dose vitamin K showed no clear difference in presence of PIVKA II at day 5: 0.2 mg IM versus 0.5 mg IM compared with lower dose vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 25: 0.2 mg IM versus 0.5 mg IM · preterm infants
Higher dose vitamin K showed no clear difference in presence of PIVKA II at day 25: 0.2 mg IM versus 0.5 mg IM compared with lower dose vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 5: 0.2 mg IV versus 0.2 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 5: 0.2 mg IV versus 0.2 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 5: 0.2 mg IV versus 0.5 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 5: 0.2 mg IV versus 0.5 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 25: 0.2 mg IV versus 0.2 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 25: 0.2 mg IV versus 0.2 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 25 ‐ 0.2 mg IV versus 0.5 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 25 ‐ 0.2 mg IV versus 0.5 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Percent of days abstinent · people with co‐occurring depression and alcohol dependence
1 finding from 1 review
Amount of alcohol consumed, short term (3‐6 months) measured using the number of drinks/drinking day (in past week to 30 days) · people with co‐occurring depression and alcohol dependence
1 finding from 1 review
Intervention not reported
Subgroup analysis of infants operated on at less than 70 days of age who did not clear their jaundice by six months after Kasai portoenterostomy · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Number of standard drinks consumed per day over the last 30 days · concurrent problem alcohol and illicit drug users
1 finding from 1 review
Over 50% less standard drinks per day Timeline follow back · concurrent problem alcohol and illicit drug users
Motivational interviewing (MI) showed no clear difference in greater than 50% reduction in number of standard drinks consumed per… compared with treatment (low certainty).
1 finding from 1 review
Abstinence from alcohol over the last 30 days · concurrent problem alcohol and illicit drug users
Motivational interviewing (MI) showed no clear difference in abstinence from alcohol over the last 30 days compared with treatment (low certainty).
1 finding from 1 review
Number of days with alcohol use · concurrent problem alcohol and illicit drug users
1 finding from 1 review
25% reduction of drinking days in the past 30 days · concurrent problem alcohol and illicit drug users
Brief motivational interviewing (BMI) showed no clear difference in 25% reduction of drinking days in the past 30 days compared with assessment‐only to reduce alcohol consumption (moderate certainty).
1 finding from 1 review
50% reduction of drinking days in the past 30 days · concurrent problem alcohol and illicit drug users
Brief motivational interviewing (BMI) showed no clear difference in 50% reduction of drinking days in the past 30 days compared with assessment‐only to reduce alcohol consumption (moderate certainty).
1 finding from 1 review
or more drinking days' reduction in the past 30 days · concurrent problem alcohol and illicit drug users
Brief motivational interviewing (BMI) probably leads to higher or more drinking days' reduction in the past 30 days compared with assessment‐only to reduce alcohol consumption (moderate certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage at
Percutaneous vascular interventions showed no clear difference in symptomatic intracranial haemorrhage within first 14 days compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Duration of ICU stay · mechanically ventilated ICU adults and children requiring sedation management
1 finding from 1 review
Length of hospital stay · mechanically ventilated ICU adults and children requiring sedation management
1 finding from 1 review
Number of delirium ‐ and coma‐free days (within 28 days) measured by CAM‐ICU or ICDSC · critically ill patients 18 years or older treated for respiratory failure or septic or both, cardiogenic or haemorrhagic shock who resided…
1 finding from 1 review